Pharmac inks deal with GlaxoSmithKline for new cancer, HIV and COPD drugs
The government drug-funding agency said the "bundle agreement" had allowed it to find savings on some medicines to support the funding of others. Photo:
- Bankruptcies in Japan rise for 19th month
- Attacks on U.S. base resume in revenge campaign for Gaza: monitor
- Xinhua's top 10 world news events in 2023
- U.S. dollar's power reaches tipping point, says U.S. writer
- Police respond to shooting on university campus in Las Vegas, suspect dead
- Manufacturing PMI expands in March
- Putin announces plans to run for president in 2024
- Truce deal in Gaza enters into force
- U.S. CDC concerned about salmonella outbreak linked to cantaloupes
- Putin announces plans to run for president in 2024